EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real-world experience with daridorexant for insomnia in adults with intellectual disabilities: a retrospective single-centre case series

David O'Regan

Drugs in Context · 02.07.2026 · 15 · 1

DOI: 10.7573/dic.2026-5-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs in Context, online erschienen am 02.07.2026. Verfasst von David O'Regan. Beteiligte Einrichtung: Faculty of Life Science and Medicine, King's College London, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Idorsia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic insomnia is common in adults with intellectual disabilities, yet evidence to guide pharmacological management is limited. We report a real-world case series of five adults with intellectual disabilities and multimorbidity treated with daridorexant, a dual orexin receptor antagonist approved in Europe for insomnia. Daridorexant was associated with marked improvements in sleep quality and quantity, despite complex comorbid sleep, physical, mental and neurodevelopmental disorders. Subject to the limitations of a small, uncontrolled case series, these gains were associated with other reported improvements, including a reduction in challenging behaviours, improved daytime functioning and substantial alleviation of parent and carer burden. Download the Plain Language Summary of this article: https://www.drugsincontext.com/plain-language-summaries/plain-language-summary-real-world-experience-with-daridorexant-for-insomnia-in-adults-with-intellectual-disabilities-a-retrospective-single-centre-case-series

Schlagwörter

Stichwörter der Autor:innen

adultdaridorexantdual orexin receptor antagonistsinsomniaintellectual disabilitysleep initiationsleep maintenance disorders

Autor:innen und Institutionen

  • Faculty of Life Science and Medicine, King's College London, UK.
  • Sleep Disorders Centre, NHS Guy's and St Thomas' Hospital, London, UK.

Förderung

  • Idorsia

Zitieren

APA

O'Regan, D. (2026). Real-world experience with daridorexant for insomnia in adults with intellectual disabilities: a retrospective single-centre case series. Drugs in Context, 15, 1. https://doi.org/10.7573/dic.2026-5-4

Vancouver

O'Regan D. Real-world experience with daridorexant for insomnia in adults with intellectual disabilities: a retrospective single-centre case series. Drugs in Context. 2026;15:1. doi:10.7573/dic.2026-5-4

BibTeX
@article{ORegan2026,
  author = {O'Regan, David},
  title = {Real-world experience with daridorexant for insomnia in adults with intellectual disabilities: a retrospective single-centre case series},
  journal = {Drugs in Context},
  year = {2026},
  volume = {15},
  pages = {1},
  doi = {10.7573/dic.2026-5-4}
}
Kostenlos starten →